# 30,000 Patients Later: How China's Regulatory Shortcut Is Outpacing U.S. Science

- slug: 30000-patients-later-how-chinas-regulatory-shortcut-is-outpacing-us-science
- date: 2026-03-19
- category: Biotech & Life Sciences

At a STAT Summit, researchers and pharma executives debated whether China's accelerating cell and gene therapy sector represents a competitive crisis for American biotech or simply a new reality to partner with — and the answer reveals deep disagreements about what leadership actually means.

---